Showing results (1901-1910 of 3,159) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|January 20, 2021
Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine gliomaHiroaki Katagi, Nozomu Takata, Yuki Aoi, et al.
Neuro-Oncology|February 24, 2019
The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasisRupesh Kotecha, Joseph M Kim, Jacob A Miller, et al.
Neuro-Oncology|August 11, 2019
NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastomaYifu Song, Yang Jiang, Dongxia Tao, et al.
Neuro-Oncology|May 14, 2011
Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomasHorng-Jyh Harn, Shinn-Zong Lin, Po-Cheng Lin, et al.
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Neuro-Oncology|March 8, 2011
N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomideJiang-bo Tang, David Svilar, Ram N Trivedi, et al.
Neuro-Oncology|March 25, 2011
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBMYong-Wan Kim, Ta Jen Liu, Dimpy Koul, et al.
Neuro-Oncology|June 24, 2011
Contribution of persistent C-Jun N-terminal kinase activity to the survival of human vestibular schwannoma cells by suppression of accumulation of mitochondrial superoxidesWei Ying Yue, J Jason Clark, Augusta Fernando, et al.
Neuro-Oncology|March 5, 2011
Late relapse in primary central nervous system lymphoma: clonal persistenceLakshmi Nayak, Cyrus Hedvat, Marc K Rosenblum, et al.
Neuro-Oncology|June 4, 2011
Thalamic high-grade gliomas in children: a distinct clinical subset?Christof M Kramm, Sandra Butenhoff, Ulrike Rausche, et al.
Pageof 316